Fig. 3
From: Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer
Overall survival analysis of GAL and TTC36 in early-stage basal-like/triple-negative breast cancer. A GAL expression. B TTC36 expression. N, number; HR, hazard ratio; CI, confidence interval